Use Intermountain Connect Care®
Learn More.
How can we help?
MultiCare Health System welcomes Intermountain Healthcare as a partner on the Northwest NCI Community Oncology Research Program (NW NCORP) program.
In 2014 MultiCare received a $4.2 million, five-year grant from the National Cancer Institute to offer cancer clinical trials and cancer care delivery research protocols in a community setting. Now, with the addition of Intermountain Healthcare, initiatives designed to accelerate and expand local access to cancer clinical trials for patients of all ages will now span across four states including Washington, Idaho, Alaska, and Utah. Oncologist Craig Nichols, MD, will lead the Intermountain team by providing oversight of cancer clinical trials and cancer care delivery research. Intermountain is an integrated healthcare system that includes 22 hospitals in Utah and Southern Idaho. Per Utah Cancer Registry data, they provide the majority of oncology services in their region.
MultiCare Oncologist Jack Keech, DO, and Oncologist Craig Nichols, MD (formerly with Virginia Mason) have been working together on the NW NCORP since the beginning of this project. Now, with Dr. Nichols transition to Intermountain, they will continue to increase opportunities for research in our communities and improve the care we provide our patients.
The overall goal of the National Cancer Institute NCORP program is to ensure cancer clinical trials, as well as cancer delivery research, are available in cancer patients’ home communities. This focus on community-based programs is expected to generate a broadly applicable evidence base that contributes to improved patient outcomes by hastening the transfer of knowledge from research into clinical practice.
According to the National Cancer Institute, approximately 85 percent of cancer patients are treated in their communities. More than 37,000 Washington residents are diagnosed with cancer annually. The disease is the leading cause of death in Washington, accounting for about 24 percent of all deaths statewide. More than 9,200 Utah residences are diagnosed with a malignant cancer annually. The disease is the second leading cause of death in Utah, just below heart disease, accounting for about 19 percent of all deaths statewide.
Intermountain joins Multicare and the Northwest NCI Community Oncology Research Program (NW NCORP) program, a partnership initiative designed to accelerate and expand local access to cancer clinical trials for patients of all ages across Washington, Idaho, Alaska, and Utah.